Viral Vectors and Vaccines
Bioprocessing Group
Home
People
Research
Resources
Publications
Contact
S. Ansorge
Latest
Accelerated mass production of influenza virus seed stocks in HEK-293 suspension cell cultures by reverse genetics
Critical phases of viral production processes monitored by capacitance
Generation of monoclonal pan-hemagglutinin antibodies for the quantification of multiple strains of influenza
Process intensification for high yield production of influenza H1N1 Gag virus-like particles using an inducible HEK-293 stable cell line
Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate
Production of lentiviral vectors encoding recombinant factor VIII expression in serum-free suspension cultures
Metabolic and Kinetic analyses of influenza production in perfusion HEK293 cell culture
Monitoring lentiviral vector production kinetics using online permittivity measurements
Transient transfection of serum-free suspension HEK 293 cell culture for efficient production of human rFVIII
New protocol for lentiviral vector mass production.
Recent progress in lentiviral vector mass production
Scalable production of influenza virus in HEK-293 cells for efficient vaccine manufacturing
Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures
On-line monitoring of cell size distribution in mammalian cell culture processes
Cite
×